Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vividion Therapeutics
Biotech
Vividion secures clinical-stage WRN inhibitor from Roche
Bayer’s Vividion Therapeutics secured the global rights from its partner Roche to the only covalent WRN inhibitor to have made it into the clinic.
James Waldron
Jun 4, 2025 9:21am
Illumina nets new CEO—Chutes & Ladders
Sep 8, 2023 9:30am
Bayer's acting BD chief lobbies for the job by making deals
May 24, 2023 3:00am
Former Seagen CEO takes on new role—Chutes & Ladders
Mar 24, 2023 9:30am
J&J CMO to leave after 20-year executive tenure—Chutes & Ladders
Jan 27, 2023 9:30am
Bayer's Vividion pens $930M biobucks pact with Tavros
Oct 12, 2022 7:30am
